The Steroids for Corneal Ulcers Trial

Authors:
  • JMJeena Mascarenhas
    Jeena Mascarenhas
  • RRRevathi Rajaraman
    Revathi Rajaraman
  • MRMeenakshi Ravindran
    Meenakshi Ravindran
  • PLPrajna Lalitha
    Prajna Lalitha
  • KRKathryn J. Ray
    Kathryn J. Ray
  • KHKevin C. Hong
    Kevin C. Hong
  • COCatherine E. Oldenburg
    Catherine E. Oldenburg
  • SLSalena M. Lee
    Salena M. Lee
  • MZMichael E. Zegans
    Michael E. Zegans
  • SMStephen D. McLeod
    Stephen D. McLeod

Abstract
Infectious corneal ulcers are a major cause of vision loss, with an annual occurrence estimated conservatively at 1.5 to 2 million globally.1 The World Health Organization estimates that corneal opacities, including corneal ulceration, are the fourth leading cause of blindness.2 Studies in South India indicate that approximately half of corneal ulcers are bacterial, and this proportion is typically higher in the United States and Europe.3-6 Clearance of the infectious agent in bacterial keratitis is usually successful, yet visual outcomes may be poor. Scarring that accompanies the resolution of infection is thought to be a major contributor to visual impairment.

This publication has 23 references indexed in Scilit: